Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,813 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis.
Yamamoto S, Iihara H, Uozumi R, Kawazoe H, Tanaka K, Fujita Y, Abe M, Imai H, Karayama M, Hayasaki Y, Hirose C, Suda T, Nakamura K, Suzuki A, Ohno Y, Morishige KI, Inui N. Yamamoto S, et al. Among authors: tanaka k. BMC Cancer. 2022 Mar 23;22(1):310. doi: 10.1186/s12885-022-09392-9. BMC Cancer. 2022. PMID: 35321690 Free PMC article. Clinical Trial.
Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting.
Tanaka K, Inui N, Karayama M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Kusagaya H, Matsuura S, Uto T, Hashimoto D, Matsui T, Asada K, Suda T. Tanaka K, et al. Cancer Chemother Pharmacol. 2019 Jul;84(1):147-153. doi: 10.1007/s00280-019-03868-5. Epub 2019 May 13. Cancer Chemother Pharmacol. 2019. PMID: 31087137 Clinical Trial.
Development of a novel T cell-oriented vaccine using CTL/Th-hybrid epitope long peptide and biodegradable microparticles, against an intracellular bacterium.
Tanaka K, Enomoto N, Uehara M, Furuhashi K, Sakurai S, Yasui H, Karayama M, Hozumi H, Suzuki Y, Fujisawa T, Inui N, Nakamura Y, Nagata T, Suda T. Tanaka K, et al. Microbiol Immunol. 2020 Oct;64(10):666-678. doi: 10.1111/1348-0421.12836. Epub 2020 Oct 5. Microbiol Immunol. 2020. PMID: 32786043 Free article.
Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials.
Yamamoto S, Iihara H, Uozumi R, Kawazoe H, Tanaka K, Fujita Y, Abe M, Imai H, Karayama M, Hayasaki Y, Hirose C, Suda T, Nakamura K, Suzuki A, Ohno Y, Morishige KI, Inui N. Yamamoto S, et al. Among authors: tanaka k. BMC Cancer. 2021 Jul 19;21(1):832. doi: 10.1186/s12885-021-08572-3. BMC Cancer. 2021. PMID: 34281514 Free PMC article. Clinical Trial.
Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial.
Inui N, Suzuki T, Tanaka K, Karayama M, Inoue Y, Mori K, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Matsuura S, Nishimoto K, Matsui T, Asada K, Hashimoto D, Fujii M, Niwa M, Uehara M, Matsuda H, Koda K, Ikeda M, Inami N, Tamiya Y, Kato M, Nakano H, Mino Y, Enomoto N, Suda T. Inui N, et al. Among authors: tanaka k. J Clin Oncol. 2024 Aug 10;42(23):2780-2789. doi: 10.1200/JCO.24.00278. Epub 2024 Jun 4. J Clin Oncol. 2024. PMID: 38833659 Free PMC article. Clinical Trial.
Immune checkpoint inhibitor-induced autoimmune limbic encephalitis with positivity for anti-Hu antibodies in a patient with small-cell lung cancer: A case report and literature review.
Nakahara L, Matsuura S, Suzuki R, Kawamura A, Nagasaki T, Masuda T, Yamada K, Nakamura R, Hiramatsu T, Akiyama N, Tanaka K, Koshimizu N, Igasaki S. Nakahara L, et al. Among authors: tanaka k. Respirol Case Rep. 2024 Nov 25;12(11):e70070. doi: 10.1002/rcr2.70070. eCollection 2024 Nov. Respirol Case Rep. 2024. PMID: 39588329 Free PMC article.
18,813 results
You have reached the last available page of results. Please see the User Guide for more information.